Learn about the latest research findings. Follow us on Twitter or subscribe to our RSS feed to receive our news releases. Contact our press office to be added to our media list or to arrange an interview.
Latest News
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
|
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl
Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
|
For younger adults 19 to 30, marijuana, vaping, hallucinogen use are at or near historically high levels
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
|
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care
Xylazine appears to worsen the life-threatening effects of opioids in rats
|
NIH study deepens understanding of possible mechanism through which xylazine impacts overdose risk
Men died of overdose at 2-3 times greater a rate than women in the U.S. in 2020-2021
|
National data show need for more research into the factors underlying differences in sex-based vulnerability to drug use
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
|
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people
Resources for the Media
Upcoming Meetings/Events
NIDA Video News
